Visa Leads Dow as Stocks Pare Early Upside

By Josh Selway / May 28, 2019 / www.schaeffersresearch.com / Article Link

middaymarketcheckThe payments sector is in focus today amid major M&A activity

The Dow Jones Industrial Average (DJI) has pared its earlier gains, with stocks unable to maintain their positive momentum following downbeat trade comments from U.S. President Donald Trump in Japan. Visa (V) is the top Dow performer at midday, as payments stock rally in response to a big merger -- but the S&P 500 Index (SPX) is hovering around breakeven as investors monitor the sharp decline in Treasury yields. Elsewhere, the Nasdaq Composite (IXIC) is trading in positive territory thanks to strength in the tech sector.

Continue reading for more on today's market, including:

Expansion news boosts Beyond Meat stock. Goldman says to sell this big-name drugmaker. Plus, AMD bulls emerge on product unveiling; a $21.5 billion M&A deal; and Teva shares sink to new low.

midday market stats may 28

There's unusual options trading on Advanced Micro Devices, Inc. (NASDAQ:AMD) today, after the company unveiled new Ryzen CPUs. AMD stock is trading up 9.6% at $28.96, and short-term call options are hot. New positions are opening at the weekly 5/31 28.50-, 28-, and 29-strike calls, while the the weekly 6/7 30-strike call is popular, as well. The chipmaker's front-month gamma-weighted Schaeffer's put/call open interest ratio (SOIR) is 1.27 -- so short-term options sentiment seemed bearish coming into today, since this reading shows put open interest outweighing call open interest among near-the-money strikes in the June series.

One of today's big winners is Total System Services, Inc. (NYSE:TSS), as the company has agreed to be bought by Global Payments Inc (GPN) for $21.5 billion in stock. TSS stock is trading up 6.5% at $120.79, putting its market cap right near the value of the deal.

total systems stock may 28

One of the worst stocks on the Nasdaq is Teva Pharmaceutical Industries Inc. (NASDAQ:TEVA). The shares of the generic drugmaker fell 9.1% to $9.88, touching a nearly two-decade low in the process. Sparking the sell-off was news of the company's $85 million settlement with the state of Oklahoma.

Recent News

Platinum, palladium, copper gain on green China, supply constraints

September 29, 2025 / www.canadianminingreport.com

Gold stocks continue to soar as markets stumble

September 29, 2025 / www.canadianminingreport.com

Gold stocks again reach new highs

September 22, 2025 / www.canadianminingreport.com

Silver outpaces major metals in recent months

September 22, 2025 / www.canadianminingreport.com

Another 'Bubble Check' for the gold sector

September 08, 2025 / www.canadianminingreport.com
See all >
Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok